MYD88 mutation is an oncogenic event strongly associated with ABC-DLBCL and Waldenstrom macroglobulinemia, the recurrent L265P mutation of MYD88 accounts for the majority of this association (63,64). This evidence concerns the gene MYD88 and diffuse large B-cell lymphoma.